ETP Capital finds, invests in, and builds innovative companies in the biomedical industry. The firm supports portfolio companies by facilitating strategic alliances, recruiting management, and acquiring new products and technologies to accelerate growth globally.

ETP Capital

Google Maps

OpenResty

Network Solutions DNS

Shockwave Flash Embed

Network Solutions

Wei-Wu He

Founder & General Partner

Help patients with complex conditions find the right doctors.

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.

CASI focus on building a pipeline through mutually beneficial business development transactions.

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging.

CGI Pharmaceuticals, Inc. is a private, development-stage pharmaceutical company.

Atto BioScience is a Rockville-based biotech company.

Intradigm Corporation is a biotechnology company developing systematic RNA interference therapeutics.

United States Venture Capital Investors (Top 10K)

West Coast Early Stage Venture Investors

Venture Capital Investors with Investments in Switzerland

Early Stage Venture Investors with Investments in California (Top 10K)

Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providing superior returns to their investors.

ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.

San Francisco

California

United States

North America

Emerging Technology Partners

After Valuation Plummet, Human Longevity Raises $30M

LIC modernises service management, moves to Microsoft Azure

Latvia

Europe

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 24, 2024 8:35 PM	6a923062
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 24, 2024 8:35 PM	7b1e5093
crunchbase trigger	general	Oct 28, 2024 1:51 PM	8c44f16c
crunchbase profile	general	Oct 29, 2024 9:06 AM	dee15d62
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	2f3edd2c
peers	general	Oct 24, 2024 8:35 PM	48601512
news basic	general	Oct 24, 2024 8:35 PM	3a901fc4
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ETPV

COM:ETPVC

ETP Capital